Mangoceuticals borrows $75K at 18% from CEO-controlled trust; matures Dec 2026

MANGOCEUTICALS, INC.

On Dec 4, 2025, borrowed $75,000 from The Tiger Cub Trust, controlled by CEO Jacob D. Cohen.
Promissory note bears 18% annual interest, compounded monthly, maturing Dec 4, 2026 or earlier upon qualified financing.
Mandatory prepayment plus make-whole premium due within 5 business days of a qualified financing (any capital raise after note date).
Default triggers automatic increase to principal plus make-whole amount and acceleration at 18% default rate.
Related-party loan from CEO's trust; cash infusion signals near-term liquidity need.

item 1.01 item 2.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

MANGOCEUTICALS, INC. entered into Promissory Note with The Tiger Cub Trust valued at $75,000 (effective 2025-12-04).

Action: entry
Agreement: credit facility
Counterparty: The Tiger Cub Trust
Value: $75,000
Effective: 2025-12-04

Exact text from the filing

On December 4, 2025, Mangoceuticals, Inc. (the “ Company ”, “ we ” and “ us ”), borrowed $75,000 from The Tiger Cub Trust, which trust is controlled by the Company’s Chief Executive Officer and Chairman, Jacob D. Cohen (“ Tiger Cub ”), and entered into a Promissory Note with Tiger Cub to evidence such loan.

View on SEC.gov

38 material agreements filed in the last 30 days. Browse all material agreements →

MANGOCEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001493152-25-027009

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.